Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dianova is a German life science tools and diagnostics company focused on distributing antibodies, immunoassays, and molecular biology products, while also manufacturing proprietary primary antibodies for histopathology. Founded in 1982 and based in Hamburg, the company serves research and routine diagnostic laboratories in universities, hospitals, and the pharmaceutical industry, particularly across Germany, Austria, and Switzerland. Dianova has been part of BIOZOL since late 2020 following its acquisition by Calibre Scientific, and its products are now positioned within a broader international life science distribution network. The company is best characterized as a commercial-stage supplier of research and diagnostic products rather than a therapeutic drug developer, with a notable emphasis on secondary antibodies and validated pathology antibodies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dianova.